Literature DB >> 2262566

Bone marrow stromal cell changes in haematological malignancies.

S A Dilly1, C J Jagger.   

Abstract

Stromal cell numbers from subjects with no haematological disease and those with acute myeloid leukaemia (AML), chronic granulocytic leukaemia (CGL), acute lymphatic leukaemia (ALL) and non-Hodgkin's lymphoma (NHL) were compared to determine their role in malignancy. Frozen sections of trephine biopsy specimens from iliac crests were stained for endogenous alkaline phosphatase activity, endogenous acid phosphatase activity, and, using immunocytochemical methods, for endothelial cells (anti-factor-VIII related antigen) and macrophages and related cells (EBM/11). In granulocytic malignancies, whether acute or chronic, alkaline phosphatase positive reticulum cells (AL-RC) and vascular endothelial cells were generally increased. In lymphoid malignancies, the numbers of AL-RC were generally reduced. Numbers of vascular endothelial cells seemed to be normal in ALL but reduced in foci of NHL. Macrophages are numerous in normal marrow, and their numbers seemed to be normal in granulocytic lesions but were more variable and sometimes reduced in ALL and NHL. Lymphoid malignancies, therefore, have a destructive effect on some stromal elements; granulocytic malignancies are associated with normal or increased numbers of stromal cells. A possible consequence of depleted stromal cells might be slower reconstitution of normal haemopoiesis after treatment. The large numbers in granulocytic malignancies raises the possibility of synergistic stimulation between stromal and neoplastic cells.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2262566      PMCID: PMC502908          DOI: 10.1136/jcp.43.11.942

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


  7 in total

1.  Monoclonal antibody EBM/11: high cellular specificity for human macrophages.

Authors:  P M Kelly; E Bliss; J A Morton; J Burns; J O McGee
Journal:  J Clin Pathol       Date:  1988-05       Impact factor: 3.411

Review 2.  Stromal cell and factor-dependent B lymphopoiesis in culture.

Authors:  P W Kincade; P L Witte; K S Landreth
Journal:  Curr Top Microbiol Immunol       Date:  1987       Impact factor: 4.291

Review 3.  The role of stromal cells and growth factors in haemopoiesis and modulation of their effects by the src oncogene.

Authors:  T M Dexter; A D Whetton; E Spooncer; C Heyworth; P Simmons
Journal:  J Cell Sci Suppl       Date:  1985

Review 4.  Stromal cell regulation of lymphoid and myeloid differentiation.

Authors:  P J Quesenberry; I K McNiece; B E Robinson; T A Woodward; G B Baber; H E McGrath; P C Isakson
Journal:  Blood Cells       Date:  1987

5.  Alkaline phosphatase positive precursors of adipocytes in the human bone marrow.

Authors:  P Bianco; M Costantini; L C Dearden; E Bonucci
Journal:  Br J Haematol       Date:  1988-04       Impact factor: 6.998

6.  Hematopoietic factor production by a cell line (TC-1) derived from adherent murine marrow cells.

Authors:  Z X Song; R K Shadduck; D J Innes; A Waheed; P J Quesenberry
Journal:  Blood       Date:  1985-08       Impact factor: 22.113

7.  Association of alkaline-phosphatase-positive reticulum cells in bone marrow with granulocytic precursors.

Authors:  H Westen; D F Bainton
Journal:  J Exp Med       Date:  1979-10-01       Impact factor: 14.307

  7 in total
  3 in total

Review 1.  Histology of normal haemopoiesis: bone marrow histology. I.

Authors:  B S Wilkins
Journal:  J Clin Pathol       Date:  1992-08       Impact factor: 3.411

2.  Stromal cell populations in necropsy bone marrow sections from allogeneic marrow recipients and non-transplant patients.

Authors:  S A Dilly; C J Jagger; J P Sloane
Journal:  J Clin Pathol       Date:  1993-07       Impact factor: 3.411

Review 3.  Angiogenesis Status in Patients with Acute Myeloid Leukemia: From Diagnosis to Post-hematopoietic Stem Cell Transplantation.

Authors:  M Mohammadi Najafabadi; K Shamsasenjan; P Akbarzadehalaleh
Journal:  Int J Organ Transplant Med       Date:  2017-05-01
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.